e-learning
resources
Berlin 2008
Sunday, 05.10.2008
Socioepidemiological studies in obstructive sleep apnoea
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Obstructive sleep apnoea doesn‘t increase risk of cardiovascular morbidity and mortality in patients with arterial hypertension
M. Bolotova, A. Litvin, P. Galitsin, I. Kolos, A. Aksyonova, I. Chazova (Moscow, Russian Federation)
Source:
Annual Congress 2008 - Socioepidemiological studies in obstructive sleep apnoea
Session:
Socioepidemiological studies in obstructive sleep apnoea
Session type:
Thematic Poster Session
Number:
881
Disease area:
Sleep and breathing disorders
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
M. Bolotova, A. Litvin, P. Galitsin, I. Kolos, A. Aksyonova, I. Chazova (Moscow, Russian Federation). Obstructive sleep apnoea doesn‘t increase risk of cardiovascular morbidity and mortality in patients with arterial hypertension. Eur Respir J 2008; 32: Suppl. 52, 881
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Panel discussion on acute decompensated pulmonary hypertension
Adherence predictors to positive airway pressure (PAP) treatment in patients with obstructive sleep apnea (OSA)
The search for realistic evidence on the outcomes of obstructive sleep apnoea
Related content which might interest you:
Cardiovascular morbidity and mortality in patients with obstructive sleep apnea - a prospective study
Source: Annual Congress 2005 - What should we know about our SAS patients
Year: 2005
Obstructive sleep apnea syndrome and cardiovascular diseases risk in patients with COPD
Source: Annual Congress 2012 - Physiology, heart failure and respiration in relation to OSA
Year: 2012
Assessment of aortic stiffness which is a new cardiovascular morbidity and mortality predictor in patients with obstructive sleep apnea syndrome and relation with severity of the disease
Source: Eur Respir J 2006; 28: Suppl. 50, 814s
Year: 2006
Obstructive sleep apnoea and risk of cardiovascular disease in men. A follow-up study
Source: Eur Respir J 2003; 22: Suppl. 45, 22s
Year: 2003
Cardiovascular morbidity and obstructive sleep apnoea in children
Source: Annual Congress 2009 - Current developments in sleep-disordered breathing in children
Year: 2009
Is there a gender difference in cardiovascular mortality in obstructive sleep apnoea?
Source: Annual Congress 2009 - Socio-economic and epidemiological aspects of sleep apnoea
Year: 2009
Obstructive pulmonary disorder is a potential risk factor of cardiovascular diseases in obstructive sleep apnea
Source: Annual Congress 2008 - Control of breathing and respiratory disorders during sleep
Year: 2008
Cardiovascular morbidity in obstructive sleep apnoea
Source: Annual Congress 2009 - PG5 Core Curriculum Postgraduate Course: Obstructive sleep apnoea – current pathophysiological, clinical and therapeutic concepts
Year: 2009
Diet and exercise in the management of obstructive sleep apnoea and cardiovascular disease risk
Source: Eur Respir Rev, 26 (144) 160110; 10.1183/16000617.0110-2016
Year: 2017
Increased cardiovascular mortality in obstructive sleep apnoea: a 7-year follow-up
Source: Eur Respir J 2001; 18: Suppl. 33, 343s
Year: 2001
Mortality in sleep apnoea syndrome: a review of the evidence
Source: Eur Respir Rev 2007; 16: 203-210
Year: 2007
Cardiovascular risk factors and the metabolic syndrome in patients with obstructive sleep apnea
Source: Annual Congress 2008 - Cardiovascular complications in obstructive sleep apnoea
Year: 2008
The risk of future cardiovascular diseases in the patients with OSAS is dependently or independently associated with obstructive sleep apnoea
Source: Eur Respir J 2001; 17: 573-574
Year: 2001
Gender differences in global cardiovascular risk factors of obstructive sleep apnea patients
Source: Eur Respir J 2006; 28: Suppl. 50, 413s
Year: 2006
Prevalence of cardiovascular risk factors and coronary artery disease in patients with obstructive sleep apnea syndrome (OSAS) requiring CPAP treatment
Source: Eur Respir J 2006; 28: Suppl. 50, 814s
Year: 2006
Obstructive sleep apnea and cardiovascular risk in Chinese population: a Meta-analysis
Source: International Congress 2017 – Best clinical practice for the management of chronic lung diseases
Year: 2017
Obstructive sleep apnea is a risk factor for death in stroke patients – a 10-year follow-up
Source: Eur Respir J 2007; 30: Suppl. 51, 328s
Year: 2007
Obstructive sleep apnea syndrome as factor of arrhythmic syndrome emergence and increase of cardiovascular risk in patients with COPD
Source: Annual Congress 2013 –The heart of the matter: sleep disordered breathing
Year: 2013
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept